Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BKYI
stocks logo

BKYI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
1.70M
+48.95%
-0.150
-85%
1.80M
-16.08%
-0.120
-69.23%
2.20M
+50.45%
-0.070
-86.79%
Estimates Revision
The market is revising No Change the revenue expectations for BIO-key International, Inc. (BKYI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.90%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+0.90%
In Past 3 Month
Wall Street analysts forecast BKYI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast BKYI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.759
sliders
Low
2.00
Averages
2.00
High
2.00
Current: 0.759
sliders
Low
2.00
Averages
2.00
High
2.00
no data image
No Data

Valuation Metrics

The current forward P/E ratio for BIO-Key International Inc (BKYI.O) is -2.00, compared to its 5-year average forward P/E of -9.37. For a more detailed relative valuation and DCF analysis to assess BIO-Key International Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.37
Current PE
-2.00
Overvalued PE
5.97
Undervalued PE
-24.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.30
Current PS
0.00
Overvalued PS
2.61
Undervalued PS
-0.02
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

BKYI News & Events

Events Timeline

(ET)
2025-11-17
05:28:50
BIO-key Forms Strategic Alliance with Savis Group
select
2025-11-14 (ET)
2025-11-14
08:31:59
BIO-key announces Q3 earnings per share of 15 cents, compared to a loss of 39 cents in the same period last year.
select
2025-11-12 (ET)
2025-11-12
05:25:36
BIO-key forms strategic alliance with VaporVM
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-14Newsfilter
BIO-key Reports Q3 Results, Showcases Strengthened Balance Sheet for 2026 Growth Goals; Investor Call Scheduled for 10am ET Today

  • Financial Performance: BIO-key reported Q3'25 revenues of $1.55M, a decrease from $2.14M in Q3'24, primarily due to the absence of large orders from key customers that boosted the previous year's figures. The company also recorded a net loss of $964,849 for the quarter.

  • Product Launches and Partnerships: The company launched the EcoID III USB fingerprint scanner, achieving FBI FAP 20 certification, and partnered with IT2Trust to enhance its market presence in Scandinavia.

  • CyberDefense Initiative: BIO-key initiated a CyberDefense Initiative to capitalize on expected increases in global defense spending, securing a significant biometric authentication deployment with a Middle East defense organization.

  • Future Outlook: The company anticipates a strong finish to 2025, projecting full-year revenues between $6.5M and $7M, while continuing to focus on cost reduction and expanding its channel sales efforts in Europe and the Middle East.

[object Object]
Preview
2.0
11-10Benzinga
Viasat Shares Rise Approximately 13%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Viasat's Financial Performance: Viasat Inc. reported adjusted earnings of 9 cents per share, significantly beating market expectations of a loss, leading to a 13.2% increase in its share price during pre-market trading.

  • Notable Gainers in Pre-Market Trading: Several stocks saw significant gains, including Masonglory Ltd (up 113.5%), Integrated Media Technology Ltd (up 117.1%), and Greenidge Generation Holdings Inc (up 57.6%) following positive developments.

  • Major Losers in Pre-Market Trading: Lazydays Holdings Inc experienced a sharp decline of 38.6% after announcing plans to delist, while CleanCore Solutions Inc fell 30.8% due to a withdrawal of its registration statement.

  • Market Activity Overview: The article highlights various stocks' movements in pre-market trading, showcasing both significant gains and losses, reflecting a volatile market environment.

[object Object]
Preview
1.0
11-08Newsfilter
BIO-key, Provider of Digital Identity and Biometric Solutions, to Hold Q3 Investor Call on Friday, November 14th at 10 AM ET

  • Investor Call Announcement: BIO-key International, Inc. will host its third quarter investor call on November 14th at 10 a.m. ET, with results released before the market opens.

  • Leadership Participation: The call will be led by Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO, who will also conduct a Q&A session.

  • Company Overview: BIO-key specializes in biometric authentication and identity management, securing access for over 40 million users with various authentication options.

  • Engagement Channels: The company encourages engagement through its social media platforms, including Facebook, LinkedIn, and X, as well as providing investor contact information.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is BIO-Key International Inc (BKYI) stock price today?

The current price of BKYI is 0.759 USD — it has increased 4.11 % in the last trading day.

arrow icon

What is BIO-Key International Inc (BKYI)'s business?

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

arrow icon

What is the price predicton of BKYI Stock?

Wall Street analysts forecast BKYI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is BIO-Key International Inc (BKYI)'s revenue for the last quarter?

BIO-Key International Inc revenue for the last quarter amounts to 1.55M USD, decreased -27.75 % YoY.

arrow icon

What is BIO-Key International Inc (BKYI)'s earnings per share (EPS) for the last quarter?

BIO-Key International Inc. EPS for the last quarter amounts to -0.15 USD, decreased -61.54 % YoY.

arrow icon

What changes have occurred in the market's expectations for BIO-Key International Inc (BKYI)'s fundamentals?

The market is revising No Change the revenue expectations for BIO-key International, Inc. (BKYI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.90%.
arrow icon

How many employees does BIO-Key International Inc (BKYI). have?

BIO-Key International Inc (BKYI) has 41 emplpoyees as of December 05 2025.

arrow icon

What is BIO-Key International Inc (BKYI) market cap?

Today BKYI has the market capitalization of 7.95M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free